Sphingosine Kinase 2 Inhibitors: Rigid Aliphatic Tail Derivatives Deliver Potent and Selective Analogues by Srinath Pashikanti (2638048)

“…Sphingosine 1-phosphate (S1P) is a pleiotropic signaling molecule that interacts with five native G-protein coupled receptors (S1P1–5) to regulate cell growth, survival, and proliferation. …”

Sphingosine Kinase 2 Inhibitors: Rigid Aliphatic Tail Derivatives Deliver Potent and Selective Analogues by Srinath Pashikanti (2638048)

“…Sphingosine 1-phosphate (S1P) is a pleiotropic signaling molecule that interacts with five native G-protein coupled receptors (S1P1–5) to regulate cell growth, survival, and proliferation. …”

Sphingosine Kinase 2 Inhibitors: Rigid Aliphatic Tail Derivatives Deliver Potent and Selective Analogues by Srinath Pashikanti (2638048)

“…Sphingosine 1-phosphate (S1P) is a pleiotropic signaling molecule that interacts with five native G-protein coupled receptors (S1P1–5) to regulate cell growth, survival, and proliferation. …”

Sphingosine Kinase 2 Inhibitors: Rigid Aliphatic Tail Derivatives Deliver Potent and Selective Analogues by Srinath Pashikanti (2638048)

“…Sphingosine 1-phosphate (S1P) is a pleiotropic signaling molecule that interacts with five native G-protein coupled receptors (S1P1–5) to regulate cell growth, survival, and proliferation. …”

Sphingosine Kinase 2 Inhibitors: Rigid Aliphatic Tail Derivatives Deliver Potent and Selective Analogues by Srinath Pashikanti (2638048)

“…Sphingosine 1-phosphate (S1P) is a pleiotropic signaling molecule that interacts with five native G-protein coupled receptors (S1P1–5) to regulate cell growth, survival, and proliferation. …”

Sphingosine Kinase 2 Inhibitors: Rigid Aliphatic Tail Derivatives Deliver Potent and Selective Analogues by Srinath Pashikanti (2638048)

“…Sphingosine 1-phosphate (S1P) is a pleiotropic signaling molecule that interacts with five native G-protein coupled receptors (S1P1–5) to regulate cell growth, survival, and proliferation. …”

Sphingosine Kinase 2 Inhibitors: Rigid Aliphatic Tail Derivatives Deliver Potent and Selective Analogues by Srinath Pashikanti (2638048)

“…Sphingosine 1-phosphate (S1P) is a pleiotropic signaling molecule that interacts with five native G-protein coupled receptors (S1P1–5) to regulate cell growth, survival, and proliferation. …”

Word learning from a touchscreen app: 30-month-olds perform better in a passive context by Lena Ackermann (5218592)

“…</div><div><br> </div><div>These results suggest that 30-month-olds do not benefit from active learning in a touchscreen-based word learning task. These findings are in contrast to Partridge, McGovern, Yung and Kidd (2015) who find a beneficial influence of active selection in preschoolers (3-5 years). …”

Analysis framework. by Hongxun Xiang (17403860)

“…The system-change-type policy tools decreased from 1.32% in the 12th Five-Year Plan to 0.97% in the 14th Five-Year Plan. …”

Time dimension frequency chart. by Hongxun Xiang (17403860)

“…The system-change-type policy tools decreased from 1.32% in the 12th Five-Year Plan to 0.97% in the 14th Five-Year Plan. …”

Tool dimension frequency chart. by Hongxun Xiang (17403860)

“…The system-change-type policy tools decreased from 1.32% in the 12th Five-Year Plan to 0.97% in the 14th Five-Year Plan. …”

Spatial dimension frequency chart. by Hongxun Xiang (17403860)

“…The system-change-type policy tools decreased from 1.32% in the 12th Five-Year Plan to 0.97% in the 14th Five-Year Plan. …”

The glycosylated VEGFR2 found upon glucose re-exposure was not a product of a de-novo protein synthesis. by Sirin A. I. Adham (662525)

“…NRP-1 was detected in the same samples as in the previous panel (B) and it did not show a profound decrease in its expression in both MDA-MB-231BO and MDA-MB-231BR. …”

Phase Behavior and Self-Assembly of Semiflexible Polymers in Poor-Solvent Solutions by Tobia Arcangeli (19540447)

Liver injury analysis. by Véronique Cheff (14559285)

Effects of COX inhibition or B₂ antagonism on the relaxation induced by CNP. by Carolina Caniffi (444744)

Summary of subgroup analysis results. by Yongki Welliam (21030005)

“…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”

PRISMA Flow Chart 2020. by Yongki Welliam (21030005)

“…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”

Included and excluded studies. by Yongki Welliam (21030005)

“…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”

Characteristics of included studies. by Yongki Welliam (21030005)

“…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”